Do IgM antibodies protect against atherosclerosis in SLE?

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms

(2016) Mizanur Rahman et al.   CLINICAL IMMUNOLOGY

Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus

(2014) Zev Sthoeger et al.   JOURNAL OF AUTOIMMUNITY

Natural IgM: Beneficial Autoantibodies for the Control of Inflammatory and Autoimmune Disease

(2014) Caroline Grönwall et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair

(2014) M. Schwartz et al.   NEUROSCIENTIST

IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE

(2012) Caroline Grönwall et al.   CLINICAL IMMUNOLOGY

Low Levels of Antibodies Against Phosphorylcholine Predict Development of Stroke in a Population-Based Study From Northern Sweden

(2010) Roland Fiskesund et al.   STROKE

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus

(2010) Cristina Anania et al.   ARTHRITIS RESEARCH & THERAPY

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

(2009) Meng-Yun Chou et al.   JOURNAL OF CLINICAL INVESTIGATION